Pharmaceutical compositions of cell lysate and processes for the production and use thereof
AssigneeInnogenetics N.V.
InventorsChris Vervaet, Jean-Paul Remon, Bernard Delaey, Peter De Waele
Life of this patent
Estimating the term…
Loading patent…
AssigneeInnogenetics N.V.
InventorsChris Vervaet, Jean-Paul Remon, Bernard Delaey, Peter De Waele
Estimating the term…
The present invention relates to a pharmaceutical composition comprising a non-viable cell lysate and at least one antiflocculant and/or antisedimentation agent(s). The pharmaceutical composition of the present invention comprising the cell lysate is in the form of a solution or a suspension or a lyophilisate, in particular, the homogenized cell lysate compositions are in the form of solutions or suspensions or lyophilisates. The present invention further discloses processes for the production and the use of the pharmaceutical composition.
A pharmaceutical composition comprising a non-viable cell lysate and at least one antiflocculant and/or antisedimentation agent(s), wherein the antiflocculant and/or antisedimentation agent is xanthan gum.
A process for the production of a homogenized pharmaceutical composition comprising the steps of growing, lysing and drying the cells, which process is characterized in that, immediately after lysing, antiflocculant and/or antisedimentation agents are added to stabilize the cell lysate mixture, wherein the antiflocculant/antisedimentation agent is xanthan gum.
Dependencies are inferred from the claim text.